On May 31st, Burning Rock Biotech's short interest dropped by 26.3% to 40,300 shares, with a 7.5-day short interest ratio and 0.
Burning Rock Biotech (BNR) experienced a 26.3% drop in short interest from 54,700 shares on May 15th to 40,300 shares on May 31st. Short interest ratio stands at 7.5 days with 0.5% of shares sold short. In Q3, Lansdowne Partners UK LLP acquired 122,593 shares worth $119,000, owning 0.12% of the company. Institutional investors hold 30.03% of the stock, with BNR shares staying at $7.71 on Friday.
June 15, 2024
3 Articles